94 citations · 126 across the 5 of their papers we have counts for
4 papers · 1 filter
DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
Cheng-Han Yang, Peter F. Thall, Ruitao Lin
Phase 1-2 designs provide a methodological advance over phase 1 designs for dose finding by using both clinical response and toxicity. A phase 1-2 trial still may fail to select a…
A Bayesian Feature Allocation Model for Identification of Cell Subpopulations Using Cytometry Data
Arthur Lui, Juhee Lee, Peter F. Thall +3
A Bayesian feature allocation model (FAM) is presented for identifying cell subpopulations based on multiple samples of cell surface or intracellular marker expression level data o…
A Decision-Theoretic Comparison of Treatments to Resolve Air Leaks After Lung Surgery Based on Nonparametric Modeling
Yanxun Xu, Peter F. Thall, Peter Mueller +1
We propose a Bayesian nonparametric utility-based group sequential design for a randomized clinical trial to compare a gel sealant to standard care for resolving air leaks after pu…
Bayesian Nonparametric Estimation for Dynamic Treatment Regimes with Sequential Transition Times
Yanxun Xu, Peter Mueller, Abdus S. Wahed +1
Dynamic treatment regimes in oncology and other disease areas often can be characterized by an alternating sequence of treatments or other actions and transition times between dise…